Menu
  • Join
  • Login
  • Contact
 

Search abstracts


CORTICOSTEROID DECREASE THE FEVER INCIDENCE AFTER THE ADMINISTRATION OF BLEOMYCIN DURING CHEMOTHERAPY WITH BLEOMYCIN, ETOPOSIDE AND CISPLATIN

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Poster
  • By: USHINOHAMA, Kazami (Kagoshima University Hospital, Pharmacy, Kagoshima, Japan)
  • Co-author(s): Kazami Ushinohama
  • Abstract:

    The combination of bleomycin, etoposide and cisplatin (BEP) is the most widely used treatment for germ cell tumors. Fever is one of the main adverse effects of bleomycin. However, the details of fever during BEP regimen and effects of premedication remain unclear.

    We retrospectively reviewed the clinical data for 22 cases treated with BEP regimen

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses